CompoAtlas

Adapto

Food supplement declared in France, declaration No 2021-7-1202, decision dated 23 July 2021

Adapto is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
Handi-Move nv
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Capsule
Daily dose
1 capsule
Directions for use
1 capsule par jour
Not recommended for (according to the manufacturer)
Sous anticoagulants

Declaration 271354, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Eleutherococcus senticosus (Rupr. et Maxim.) MaximRacineExtrait sec hydroalcoolique110 mg
Sedum roseum (L.) Scop.RacineExtrait sec hydroalcoolique110 mg
Lepidium meyenii Walp.RacineExtrait sec hydroalcoolique100 mg
Withania somnifera (L.) DunalRacineExtrait sec aqueux90 mg
Schisandra chinensis (Turcz.) Baill.BaieExtrait sec hydroalcoolique50 mg

Additives

E464, E471

Other ingredients

farine de riz

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2021. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux personnes sous anticoagulants.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line